In less than 48 hours, President Trump retreated on his promise of sweeping healthcare reform and the claim that the Republican party would be the party of healthcare. Trump now says he will wait until after the 2020 election, perhaps making it an even more contentious issue for voters.
Trump had pledged in recent days to use court action to end the Affordable Care Act and said the Republican Party would push over the next few months for a better healthcare plan at lower cost for most Americans.
But Republican leaders in Congress quickly shied away from the issue and pushed him to reconsider.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
HCA's Aroon Indicator triggered a bullish signal on September 02, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 313 similar instances where the Aroon Indicator showed a similar pattern. In 229 of the 313 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 73%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 30 of 49 cases where HCA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on HCA as a result. In 60 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
HCA moved above its 50-day moving average on September 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCA advanced for three days, in 248 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for HCA turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 31 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-140.595) is normal, around the industry mean (208.195). P/E Ratio (14.507) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (1.323) is also within normal values, averaging (2.498). Dividend Yield (0.007) settles around the average of (0.005) among similar stocks. P/S Ratio (1.264) is also within normal values, averaging (2.688).
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. HCA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of health care services
Industry HospitalNursingManagement